Manganese is an essential trace element however elevated environmental and occupational exposure to this element has been correlated with neurotoxicity symptoms clinically identical to idiopathic Parkinson's disease. In the present study we chronically exposed human neuroblastoma SH-SY5Y cells to manganese (100µM) and carried out expression profiling of miRNAs known to modulate neuronal differentiation and neurodegeneration. The miRNA PCR array results reveal alterations in expression levels of miRNAs, which have previously been associated with the regulation of synaptic transmission and apoptosis. The expressions of miR-7 and miR-433 significantly reduced upon manganese exposure. By in silico homology analysis we identified SNCA and FGF-20as targets of miR-7 and miR-433. We demonstrate an inverse correlation in expression levels where reduction in these two miRNAs causes increases in SNCA and FGF-20. Transient transfection of SH-SY5Y cells with miR-7 and miR-433 mimics resulted in down regulation of SNCA and FGF-20 mRNA levels. Our study is the first to uncover the potential link between manganese exposure, altered miRNA expression and parkinsonism: manganese exposure causes overexpression of SNCA and FGF-20 by diminishing miR-7 and miR-433 levels. These miRNAs may be considered critical for protection from manganese induced neurotoxic mechanism and hence as potential therapeutic targets.
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Introduction
Manganese (Mn) is the most prevalent transition metal in the environment but is only required in trace amounts for normal growth and brain development (Sandstead, 1986) . Mn is an essential cofactor for various enzymes involved in carbohydrate and protein metabolism and for antioxidant enzymes such as superoxide dismutase (SOD) (Guilarte TR, 2013) . Mn levels are tightly regulated in the human body and exposure to elevated concentrations cause manganism, a neurological disorder with clinical symptoms resembling those of idiopathic Parkinson's disease (Racette BA et al., 2012a , 2001b . Mn can be an occupational healthrisk. For example, miners and workers in ferroalloy, smelting and metallurgy industries are often exposed to Mn, primarily
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A N U S C R I P T 4 through inhalation (Finkelstein MM, 2007; Lucas E.L et al., 2015) . It is possible that rural populations are at greater risk of developing Parkinson's disease considering their frequent exposure to Maneb and Paraquat, pesticides containing Mn (Ritz et al, 2000; Roede JR et al., 2011) . Also populations that depend Mn contaminated drinking water at levels exceeding the WHO regulatory standard (400µg/L) have been shown to express increased risk of neurological deficits (WHO, 2006; Ljung K, 2007) . Elevated levels of Mn can also be released into the atmosphere as a combustion product since methylcyclopentadienyl manganese tricarbonyl (MMT) is used to improve fuel oil combustion (Crump, 2000; Su C et al., 2015) . High dosage consumption of Mn containing psychoactive formulations have been associated with parkinsonism (de Bie R et al., 2007) .
The globus pallidus is a primary site for Mn accumulation within the brain while other studies also suggests deposition in the substantia nigra, a brain structure that produces dopamine (Park JD et al., 2007) . Progressive loss of dopaminergic neurons in the substantia nigra due to
Mn accumulation could be a pathophysiological cause of parkinsonism (Peneder TM et al., 2011 ). Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons and the presence of Lewy neurites (LNs) and proteinaceous inclusions known as Lewy bodies (LBs) in dopaminergic neurons (Hashimoto, M et al., 2009; Recchia A et al., 2004) . A major component of LBs are peptides encoded by α-Synuclein (SNCA) (Spillantini M. G et al., 1997) . Altered SNCA expression levels have been found to be associated with several neurodegenerative diseases including Parkinson's disease (Recchia A et al., 2004) . Mn exposure can induce overexpression of SNCA, causing neuronal apoptosis Jason P, 2011; Li Y et al., 2010) . The upstream regulatory events leading to SNCA over-expression have not been well
established. Our previous work suggests the possible role of Mn induced epigenetic changes in parkinsonism through mitochondrial dysfunction (Tarale et al., 2017 (Tarale et al., , 2016 .
MicroRNAs (miRNAs) are 17-24 base small non-coding, single stranded RNAs that regulate gene expression post-transcriptionally via binding to the 3'-untranslated region (UTR) of mRNAs, thereby repressing the translation process (Gartel AL, 2008; He L, 2004) .
Dysregulation of miRNA expression was recently identified as contributing to a higher risk of neurodegeneration (Johnson R et al., 2012) . Altered expression of miRNAs, such as miR-29a/b-1, miR-19, miR-101 and miR-130 has been associated with neurodegenerative disorders (Hébert SS et al., 2008) . Additionally, miR-7 and mir-433 have been found to regulate the expression of SNCA in normal and PD brain, as well as in animal models of PD, for example, the worm C.
elegens (Asikainen S, Rudgalvyte M, 2010; Gillardon F, Mack M, 2008; Junn E et al., 2009; Vartiainen S et al., 2006; Wang G et al., 2008) . The potential role of miRNAs in manganese exposed cell models and the implications in the etiology of Parkinson's disease have not been yet explored.
In the present investigation we profiled the expression of 84 different miRNAs known to be differentially expressed during neuronal development or in neurodegeneration. We used a miRNA PCR array and measured expression changes in the dopaminergic human neuroblastoma cell line SH-SY5Y following a chronic manganese exposure. This represents the first study to demonstrate a connection between Mn exposure, miRNA deregulation and Parkinson's disease.
Material and Methods
Cell line
Human neuroblastoma (SH-SY5Y) cell line was obtained from National Center for Cell Science (NCCS), Pune, India. Cells were grown in Ham's F-12 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 50 g/mL streptomycin, and 25 g/mL Fungizone.
Cells were maintained at 37 ∘ C in a humidified atmosphere with 5% CO2.
Chronic Mn
2+ exposure SH-SY5Y cells were seeded in 25mm 2 flask (5 x10 5 cells/ml) and grown to 70% confluence when they were exposed to 100 µM of Mn 2+ in the form of MnCl2 (Sigma Aldrich, USA). The Concentration was selected from the dose response relationship (24hrs) for Mn exposed SH-SY5Y cells (Supplementary figure 1) . This is also within the range of concentration from previous studies that used human astrocytes and human brain samples. Mn concentrations shown to be toxic are in the range 60.1-158.4 µM (Bowman AB., and Aschner, 2014) . Mn exposures ≥50 µM (from 0 to 100µM) have been found to impact the redox processes in human neuroblastoma cell mitochondria corresponding to toxic range of Mn in human brain . Three replicates of controls (culture medium only) and three replicates of Mnexposed cultures were maintained for a period of 30 days. The medium was changed every 72 hours after each passage throughout the period of exposure. Mn 2+ was added after each cell passage after cells started to adhere to the surface of the flasks (it took approximately 3-4 hours for cells to adhere). We also evaluated the viability of cells at each cell passage using a trypan blue exclusion assay (Supplementary figure 2). The viability of exposed cells remains at ~85%
throughout the period of chronic exposure. This indicates there is not a development of tolerance for Mn over the period of exposure.
miRNA profiling
At the end of the exposure period, total miRNA was harvested from the cells using the mirPremier microRNA Isolation Kit (Sigma Aldrich, USA) as per the manufacturer protocol.
miRNA was quantified using a NanoDrop 8000 spectrophotometer. miRNA profiling was carried out using the Qiagen human neurological development and disease miScriptmiRNA PCR array, to analyse the differential expression of 84 miRNAs involved in neuronal development or progression of neurological diseases (Supplementary table 1) . 12 wells of each miScriptmiRNA PCR array plate were controls (SNORD61, SNORD68, SNORD72, SNORD95, SNORD96A, RNU6-6P). These controls were used for normalization of RT-PCR data for endogenous miRNAs in the samples. 200 ng of miRNA was converted to cDNA using miScript II RT kit (Qiagen, Germany) as per the manufacturer instructions. Real time PCR for mature miRNA expression profiling was performed using diluted cDNA according to the manufacturer's protocol. Applied Biosystems 7300 real time PCR system was used for RT-PCR. Data were collected to perform quantification using the ΔΔCt method of relative quantification and interpretation of control wells (Tarale et al., 2017) .
In silico Hybridisation Analysis
In silico hybridisation studies were performed using the mirTarBase and miRANDA software (August 2010 release; http://www.microrna.org/microrna/home.do) to screen and predict possible mRNA targets of differentially expressed miRNAs. miR-433-3p and miR-7-5p
were selected for this in silico analysis based on their significant differential expression detected
in our study and their established role in Parkinson's disease (Wang G et al., 2008) ( Supplementary table 1) . Additionally, other miRNAs were screened for their possible mRNA targets. Supplementary file 1 gives the list of these miRNAs along with their target genes and associated biological functions. The list of potential target genes was submitted to Database for Annotation, Visualization and Integrated Discovery (DAVID) version 6.7 for functional annotation clustering.
Real time quantitative PCR
Validation of screened miRNAs (miR-433-3p/miR-7-5p) was carried out using quantitative real time PCR (qRT-PCR). Isolation of miRNAs was carried using the mirPremier microRNA Isolation Kit (Sigma Aldrich, USA) as per the manufacturer protocol. 500 ng of miRNA was converted to cDNA using the NCode VILO miRNAcDNA Synthesis Kit (Invitrogen, USA). Relative quantification of miRNA was performed on Applied Biosystems 7300 real time PCR system using EXPRESS SYBR GreenERqPCRSuperMix containing universal reverse primers (Invitrogen, USA) and forward customized primers of miR-433-3p/miR-7-5p (Table 1 ). RUN48 was used as an internal control in the real time qRT-PCR (Nurul et al., 2012) . ddCT (2 ∧ -ddCt) method was used for calculation of fold change.
For expression-validation of possible mRNA targets, total RNA was isolated using the Trizol (Invitrogen, USA) reagent. RNA was quantified using a NanoDrop 8000 spectrophotometer.
High Capacity Reverse Transcription kit (Applied Biosystems, USA) was used for converting 2 µg of total RNA to cDNA. qRT-PCR primers for SNCA and FGF-20 were used (Table 1) and validated before relative quantification. RNA polymerase II (RPII) and hypoxanthine phosphoribosyltransferase (HPRT) were used as internal controls (Sain S et al., 2014) . Relative
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Statistical analysis
Student's t test (paired, 2-tailed) in Microsoft Excel was used to determine the statistical significance between the values in control and exposed samples.
Results
Deregulation of miRNA expression is implicated in critical neuronal pathways
The miRNAs sampled by the miScriptmiRNA PCR array include a set of miRNAs known to be associated with various neuronal disorders (Supplementary table 1 DAVID analysis indicates that these putative target genes are primarily involved in processes of apoptosis (21%), gene expression (21%), phosphorylation (19%) and synaptic transmission ACCEPTED MANUSCRIPT
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(10%) ( Figure 2B ). We narrowed our screen of 80 putative miRNA target genes and focused on genes known to be associated with Parkinson's disease (Supplementary table 1 
miR-7 and miR-433 identified as regulators of SNCA expression
An in-silico homology analysis identified SNCA and FGF-20 as putative target genes for miR-7 and miR-433, respectively (Junn E et al., 2009 ) ( Figure 3A ). miR-7 and miR-433 are 
Discussion
Manganese is an crucial trace element however chronic environmental and occupational exposure reported to cause neurological deficits with symptoms clinically resembling to idiopathic Parkinson's disease (Su C et al., 2015) . Elevated expression of SNCA considered to ACCEPTED MANUSCRIPT
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A N U S C R I P T 13 be toxic for dopaminergic neuronal cells and frequent molecular pathological findings in brain tissue samples from Parkinson's disease patients (Recchia A et al., 2010) . Various genetic and environmental factors may have the potential to cause elevated SNCA expression (reviewed in Tarale et al., 2016) . Mn exposure has been reported to cause over-expression of SNCA in the neuronal SH-SY5Y cell line (Li Yet al., 2009) . Our work provides evidence that Mn-exposure leads to deregulation of certain miRNAs. These miRNAs and their potential target mRNAs regulate apoptosis and synaptic transmission, processes which are critically important for neuronal cell health (Figure 2A and B).
Among the list of deregulated miRNAs, we selected miR-7 and miR-433 to further dissect their role in manganese neurotoxicity. Expression of miR-7 and miR-433 was down-regulated following Mn exposure ( Figure 3B ). We also identified SNCA and FGF-20 as putative targets of miR-7 and miR-433 ( figure 3A ).
The upstream mechanisms causing down-regulation of miR-7 and miR-433 are unknown.
However, Mn exposure is known to cause neuronal cell apoptosis through oxidative stress mechanisms (Stephenson et al., 2013; Fernandes et al., 2017) . Alterations in the redox balance of primary human brain cells exposed to iron-plus aluminum-sulfate can cause deregulation of specific miRNAs via ROS generation ( Lukiw and Aileen, 2007) . We hypothesise that oxidative stress and its effect on redox sensitive transcription factors may lead to altered expression of miRNAs, which in turn influence a gene programme important in PD. (Cannon JR and Greenamyre, 2010) .
Our present study suggests a role for miR-7 in Mn-induced neurodegeneration by causing SNCA overexpression.
Fibroblast growth factor 20 (FGF-20) is expressed in the substangia nigra and may preserve the function of neurotrophic activity in dopaminergic neurons (Ohta, 2013) . FGF20 has been suggested as another candidate gene responsible for Parkinson's disease in Japanese and Chinese populations (Pan et al., 2012) ; though not in Finnish and Greek populations (Satake et al., 2008; Christian et al., 2009) .
A sequence polymorphism in the 3' UTR of FGF20 elevates the risk of Parkinson's disease and is most likely caused by disruption of a binding site for microRNA-433 (Wang G et al., 2008) .
Homozygosity of this FGF-20 variant is not only associated with an elevation of FGF-20
expression, but also with an increase in SNCA protein levels (Wang G et al., 2008) . In the present work we show that elevated FGF-20 expression is closely associated with decreased miR-433 levels.
Our transfection study with miRNA mimics strengthens the evidence that manganese exposure may cause elevation of SNCA expression via alteration in miR-7 and miR-433 levels. It will be of interest to replicate and confirm our results using animal models. The present findings indicate that two neurodegenerative disorders -manganism and idiopathic Parkinson's disease may result from misregulation of the same genetic network, which includes altered expression of miRNAs.
Our results raise the possibility of using miR-7 and miR-433 as therapeutic targets to prevent or treat manganese induced neurotoxicity.
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Conclusion
The present study identified a selection of miRNAs which are deregulated upon Mnexposure in a neuronal cell line. This list of miRNAs provides molecular entry points to further explore their regulatory roles in Mn-induced neurodegeneration. A key finding is that downregulation of miR-7 and miR-433 is closely associated with elevated SNCA expression. We provide the first indication that manganism and Parkinson's disease share common molecular mechanisms, including deregulation of miRNAs which may be targeted therapeutically. Expression of SNCA and FGF-20 were normalized with controls in manganese treated samples.
Table 1.qRT-PCR primers
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